Related Experiment Video
Updated: Aug 20, 2026

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis
Oleg Timofeev1, Ting Yi Lee, Dmitry V Bulavin
1Cell Cycle Control and Tumorigenesis Group, Institute of Molecular and Cell Biology, Singapore.
Abstract:
Emerging evidence supports a role for p38 MAPK in negative regulation of tumorigenesis. Here we show that a subtle activation of p38 MAPK is sufficient to suppress tumorigenesis as measured by the ability to form tumors when MKK6-inducible cells were explanted into nude mice. On the other hand, this activation of p38 MAPK did not necessarily cause an immediate inhibition of cell growth in vitro as measured by standard MTS assay. This data uncovers a new methodology for anti-cancer drugs screening and suggests that a substantial number of potential anti-tumor compounds, such as activators of MKK6/p38 signaling, was missed out in previous high throughput screens based on conventional growth inhibition assays.
Insights
Subtle activation of p38 mitogen-activated protein kinase (MAPK) suppresses tumor formation. This finding suggests new anti-cancer drug screening methods beyond traditional cell growth inhibition assays.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Emerging evidence suggests p38 MAPK plays a role in suppressing tumor development.
- Understanding the precise role of p38 MAPK in tumorigenesis is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the effect of subtle p38 MAPK activation on tumorigenesis.
- To explore novel anti-cancer drug screening methodologies.
Main Methods:
- Utilized MKK6-inducible cells explanted into nude mice to assess tumor formation.
- Employed standard MTS assays to measure in vitro cell growth inhibition.
Main Results:
- A subtle activation of p38 MAPK was sufficient to suppress tumor formation in vivo.
- This activation did not necessarily lead to immediate inhibition of cell growth in vitro.
Conclusions:
- p38 MAPK activation can suppress tumorigenesis independently of immediate cell growth inhibition.
- This highlights a potential limitation in current high-throughput screening assays for anti-cancer compounds.
- Suggests activators of MKK6/p38 signaling as potential anti-tumor agents missed by conventional assays.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MAPK Signaling Cascades
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity
